找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Acute Myeloid Leukemia; Christoph R?llig,Gert J. Ossenkoppele Book 2021 Springer Nature Switzerland AG 2021 Acute Myeloid Leukemia.Genomic

[復(fù)制鏈接]
樓主: Capricious
11#
發(fā)表于 2025-3-23 13:10:29 | 只看該作者
12#
發(fā)表于 2025-3-23 14:57:05 | 只看該作者
13#
發(fā)表于 2025-3-23 20:03:05 | 只看該作者
14#
發(fā)表于 2025-3-23 22:21:55 | 只看該作者
15#
發(fā)表于 2025-3-24 05:34:51 | 只看該作者
Book 2021 treatment of acute promyelocytic leukemia, current practice of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessment of measurable residual disease, immune approaches, and ideas for in
16#
發(fā)表于 2025-3-24 08:19:54 | 只看該作者
Fuels for High-Performance Flight, inhibitors (e.g., etoposide, doxorubicin), and other drugs (e.g., azathioprine) are described to be associated with the development of therapy-related AML (t-AML). Furthermore, about 5–15% of adults and 4–13% of pediatric patients with MDS or AML carry germline pathogenic variants in cancer suscept
17#
發(fā)表于 2025-3-24 12:24:56 | 只看該作者
18#
發(fā)表于 2025-3-24 16:55:17 | 只看該作者
19#
發(fā)表于 2025-3-24 21:04:31 | 只看該作者
Understanding the Basics of Aviation Noise,cytogenetic subgroups and molecular markers such as ., and ., also the screening for ., and . mutations is now recommended. In the future, a better understanding of the clonal evolution leading to malignant transformation and selection of resistant leukemia clones will not only be crucial for refine
20#
發(fā)表于 2025-3-24 23:47:05 | 只看該作者
The Unlawful Interference Conventions, therapies of varying intensity and duration have become available to choose the ideal compromise between organ toxicity and reduction of the risk of relapse in most patients up to the age of about 70 with a good performance status. Inclusion of haploidentical donors and the use of more sensitive te
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 17:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
许昌市| 巫山县| 桃江县| 白玉县| 舒兰市| 化隆| 文山县| 柏乡县| 商洛市| 望都县| 忻城县| 旌德县| 德州市| 东乌珠穆沁旗| 南和县| 蒙自县| 揭西县| 土默特右旗| 肃宁县| 南宁市| 霍城县| 新竹市| 上饶市| 兴海县| 缙云县| 治县。| 伊通| 新余市| 新营市| 珲春市| 平昌县| 乌鲁木齐县| 康马县| 丽水市| 鄱阳县| 舞阳县| 肇源县| 全南县| 桂阳县| 呈贡县| 鄂尔多斯市|